Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Publisher Correction: 3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification.

Kalinin AA, Allyn-Feuer A, Ade A, Fon GV, Meixner W, Dilworth D, Husain SS, de Wet JR, Higgins GA, Zheng G, Creekmore A, Wiley JW, Verdone JE, Veltri RW, Pienta KJ, Coffey DS, Athey BD, Dinov ID.

Sci Rep. 2018 Oct 26;8(1):16142. doi: 10.1038/s41598-018-33574-w.

2.

3D Shape Modeling for Cell Nuclear Morphological Analysis and Classification.

Kalinin AA, Allyn-Feuer A, Ade A, Fon GV, Meixner W, Dilworth D, Husain SS, de Wet JR, Higgins GA, Zheng G, Creekmore A, Wiley JW, Verdone JE, Veltri RW, Pienta KJ, Coffey DS, Athey BD, Dinov ID.

Sci Rep. 2018 Sep 12;8(1):13658. doi: 10.1038/s41598-018-31924-2. Erratum in: Sci Rep. 2018 Oct 26;8(1):16142.

3.

Characterization of Urothelial Cancer Circulating Tumor Cells with a Novel Selection-Free Method.

Chalfin HJ, Kates M, van der Toom EE, Glavaris S, Verdone JE, Hahn NM, Pienta KJ, Bivalacqua TJ, Gorin MA.

Urology. 2018 May;115:82-86. doi: 10.1016/j.urology.2018.01.036. Epub 2018 Feb 9.

PMID:
29432873
4.

The prostate metastasis suppressor gene NDRG1 differentially regulates cell motility and invasion.

Sharma A, Mendonca J, Ying J, Kim HS, Verdone JE, Zarif JC, Carducci M, Hammers H, Pienta KJ, Kachhap S.

Mol Oncol. 2017 Jun;11(6):655-669. doi: 10.1002/1878-0261.12059. Epub 2017 May 2.

5.

Nucleolin Staining May Aid in the Identification of Circulating Prostate Cancer Cells.

Chalfin HJ, Verdone JE, van der Toom EE, Glavaris S, Gorin MA, Pienta KJ.

Clin Genitourin Cancer. 2017 Jun;15(3):e477-e481. doi: 10.1016/j.clgc.2016.12.004. Epub 2017 Jan 4.

PMID:
28153390
6.

A surface tension magnetophoretic device for rare cell isolation and characterization.

van der Toom EE, Verdone JE, Jun C, Petrisor D, Lim S, de la Rosette JJ, de Reijke TM, Gorin MA, Pienta KJ, Stoianovici D.

Med Oncol. 2017 Feb;34(2):22. doi: 10.1007/s12032-016-0877-y. Epub 2017 Jan 5.

7.

Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer.

Gorin MA, Verdone JE, van der Toom E, Bivalacqua TJ, Allaf ME, Pienta KJ.

Nat Rev Urol. 2017 Feb;14(2):90-97. doi: 10.1038/nrurol.2016.224. Epub 2016 Nov 22. Review.

PMID:
27872478
8.

A simple selection-free method for detecting disseminated tumor cells (DTCs) in murine bone marrow.

Valkenburg KC, Amend SR, Verdone JE, van der Toom EE, Hernandez JR, Gorin MA, Pienta KJ.

Oncotarget. 2016 Oct 25;7(43):69794-69803. doi: 10.18632/oncotarget.12000.

9.

Technical challenges in the isolation and analysis of circulating tumor cells.

van der Toom EE, Verdone JE, Gorin MA, Pienta KJ.

Oncotarget. 2016 Sep 20;7(38):62754-62766. doi: 10.18632/oncotarget.11191. Review.

10.

A phased strategy to differentiate human CD14+monocytes into classically and alternatively activated macrophages and dendritic cells.

Zarif JC, Hernandez JR, Verdone JE, Campbell SP, Drake CG, Pienta KJ.

Biotechniques. 2016 Jul 1;61(1):33-41. doi: 10.2144/000114435. eCollection 2016.

11.

Disseminated tumor cells and dormancy in prostate cancer metastasis.

van der Toom EE, Verdone JE, Pienta KJ.

Curr Opin Biotechnol. 2016 Aug;40:9-15. doi: 10.1016/j.copbio.2016.02.002. Epub 2016 Feb 20. Review.

12.

Polyclonal breast cancer metastases arise from collective dissemination of keratin 14-expressing tumor cell clusters.

Cheung KJ, Padmanaban V, Silvestri V, Schipper K, Cohen JD, Fairchild AN, Gorin MA, Verdone JE, Pienta KJ, Bader JS, Ewald AJ.

Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):E854-63. doi: 10.1073/pnas.1508541113. Epub 2016 Feb 1.

13.

Alternative CD44 splicing identifies epithelial prostate cancer cells from the mesenchymal counterparts.

Hernandez JR, Kim JJ, Verdone JE, Liu X, Torga G, Pienta KJ, Mooney SM.

Med Oncol. 2015 May;32(5):159. doi: 10.1007/s12032-015-0593-z. Epub 2015 Apr 9.

14.

Aerobic glycolysis, motility, and cytoskeletal remodeling.

Verdone JE, Zarif JC, Pienta KJ.

Cell Cycle. 2015;14(2):169-70. doi: 10.1080/15384101.2014.995493. No abstract available.

15.

Glycolysis is the primary bioenergetic pathway for cell motility and cytoskeletal remodeling in human prostate and breast cancer cells.

Shiraishi T, Verdone JE, Huang J, Kahlert UD, Hernandez JR, Torga G, Zarif JC, Epstein T, Gatenby R, McCartney A, Elisseeff JH, Mooney SM, An SS, Pienta KJ.

Oncotarget. 2015 Jan 1;6(1):130-43.

16.

Epithelial-mesenchymal transition in prostate cancer is associated with quantifiable changes in nuclear structure.

Verdone JE, Parsana P, Veltri RW, Pienta KJ.

Prostate. 2015 Feb;75(2):218-24. doi: 10.1002/pros.22908. Epub 2014 Oct 18.

17.

The presence of androgen receptor elements regulates ZEB1 expression in the absence of androgen receptor.

Mooney SM, Parsana P, Hernandez JR, Liu X, Verdone JE, Torga G, Harberg CA, Pienta KJ.

J Cell Biochem. 2015 Jan;116(1):115-23. doi: 10.1002/jcb.24948.

Supplemental Content

Loading ...
Support Center